Beijing LabTech Instruments Co Ltd (688056) - Net Assets
Based on the latest financial reports, Beijing LabTech Instruments Co Ltd (688056) has net assets worth CN¥804.17 Million CNY (≈ $117.68 Million USD) as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥909.21 Million ≈ $133.05 Million USD) and total liabilities (CN¥105.04 Million ≈ $15.37 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Beijing LabTech Instruments Co Ltd liquidity resilience to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | CN¥804.17 Million |
| % of Total Assets | 88.45% |
| Annual Growth Rate | 18.45% |
| 5-Year Change | 10.35% |
| 10-Year Change | 444.48% |
| Growth Volatility | 36.03 |
Beijing LabTech Instruments Co Ltd - Net Assets Trend (2012–2024)
This chart illustrates how Beijing LabTech Instruments Co Ltd's net assets have evolved over time, based on quarterly financial data. Also explore 688056 asset base for the complete picture of this company's asset base.
Annual Net Assets for Beijing LabTech Instruments Co Ltd (2012–2024)
The table below shows the annual net assets of Beijing LabTech Instruments Co Ltd from 2012 to 2024. For live valuation and market cap data, see Beijing LabTech Instruments Co Ltd (688056) total market value.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | CN¥817.59 Million ≈ $119.64 Million |
-3.74% |
| 2023-12-31 | CN¥849.32 Million ≈ $124.28 Million |
+2.74% |
| 2022-12-31 | CN¥826.68 Million ≈ $120.97 Million |
+5.12% |
| 2021-12-31 | CN¥786.43 Million ≈ $115.08 Million |
+6.14% |
| 2020-12-31 | CN¥740.92 Million ≈ $108.42 Million |
+126.23% |
| 2019-12-31 | CN¥327.51 Million ≈ $47.93 Million |
+10.51% |
| 2018-12-31 | CN¥296.38 Million ≈ $43.37 Million |
+27.43% |
| 2017-12-31 | CN¥232.58 Million ≈ $34.03 Million |
+0.50% |
| 2016-12-31 | CN¥231.42 Million ≈ $33.86 Million |
+54.11% |
| 2014-12-31 | CN¥150.16 Million ≈ $21.97 Million |
+8.19% |
| 2013-12-31 | CN¥138.79 Million ≈ $20.31 Million |
+29.52% |
| 2012-12-31 | CN¥107.16 Million ≈ $15.68 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Beijing LabTech Instruments Co Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 488.3% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | CN¥306.45 Million | 37.48% |
| Common Stock | CN¥67.45 Million | 8.25% |
| Other Comprehensive Income | CN¥50.89 Million | 6.22% |
| Other Components | CN¥392.80 Million | 48.04% |
| Total Equity | CN¥817.59 Million | 100.00% |
Beijing LabTech Instruments Co Ltd Competitors by Market Cap
The table below lists competitors of Beijing LabTech Instruments Co Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Eris Technology
TWO:3675
|
$362.74 Million |
|
Universal Vision Biotechnology Co Ltd
TWO:3218
|
$363.02 Million |
|
China Fangda Group Co Ltd
SHE:000055
|
$363.04 Million |
|
SNDL Inc.
NASDAQ:SNDL
|
$363.07 Million |
|
Boston Omaha Corp
NYSE:BOC
|
$362.53 Million |
|
Bigcommerce Holdings Inc
NASDAQ:BIGC
|
$362.50 Million |
|
Arbonia AG
SW:ARBN
|
$362.43 Million |
|
Shandong Sinoglory Health
SHG:603182
|
$362.39 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Beijing LabTech Instruments Co Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 849,323,161 to 817,588,631, a change of -31,734,530 (-3.7%).
- Net income of 39,148,085 contributed positively to equity growth.
- Dividend payments of 61,250,306 reduced retained earnings.
- Share repurchases of 17,009,839 reduced equity.
- Other comprehensive income decreased equity by 1,329,083.
- Other factors increased equity by 8,706,613.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | CN¥39.15 Million | +4.79% |
| Dividends Paid | CN¥61.25 Million | -7.49% |
| Share Repurchases | CN¥17.01 Million | -2.08% |
| Other Comprehensive Income | CN¥-1.33 Million | -0.16% |
| Other Changes | CN¥8.71 Million | +1.06% |
| Total Change | CN¥- | -3.74% |
Book Value vs Market Value Analysis
This analysis compares Beijing LabTech Instruments Co Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 2.98x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 7.51x to 2.98x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2012-12-31 | CN¥4.89 | CN¥36.73 | x |
| 2013-12-31 | CN¥3.43 | CN¥36.73 | x |
| 2014-12-31 | CN¥3.02 | CN¥36.73 | x |
| 2016-12-31 | CN¥4.63 | CN¥36.73 | x |
| 2017-12-31 | CN¥4.63 | CN¥36.73 | x |
| 2018-12-31 | CN¥5.93 | CN¥36.73 | x |
| 2019-12-31 | CN¥6.55 | CN¥36.73 | x |
| 2020-12-31 | CN¥13.28 | CN¥36.73 | x |
| 2021-12-31 | CN¥11.78 | CN¥36.73 | x |
| 2022-12-31 | CN¥12.41 | CN¥36.73 | x |
| 2023-12-31 | CN¥12.63 | CN¥36.73 | x |
| 2024-12-31 | CN¥12.32 | CN¥36.73 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Beijing LabTech Instruments Co Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 4.79%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 9.23%
- • Asset Turnover: 0.44x
- • Equity Multiplier: 1.17x
- Recent ROE (4.79%) is below the historical average (14.79%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2012 | 23.50% | 13.25% | 1.06x | 1.67x | CN¥14.38 Million |
| 2013 | 23.62% | 15.49% | 0.93x | 1.64x | CN¥18.90 Million |
| 2014 | 19.51% | 13.45% | 0.95x | 1.53x | CN¥14.29 Million |
| 2016 | 19.67% | 15.68% | 0.86x | 1.47x | CN¥22.38 Million |
| 2017 | 21.16% | 15.24% | 0.89x | 1.56x | CN¥25.88 Million |
| 2018 | 20.23% | 17.09% | 0.82x | 1.44x | CN¥30.25 Million |
| 2019 | 18.77% | 16.12% | 0.85x | 1.38x | CN¥28.65 Million |
| 2020 | 8.81% | 18.71% | 0.41x | 1.15x | CN¥-8.79 Million |
| 2021 | 8.83% | 18.82% | 0.41x | 1.13x | CN¥-9.23 Million |
| 2022 | 5.40% | 12.57% | 0.37x | 1.16x | CN¥-38.04 Million |
| 2023 | 3.25% | 6.63% | 0.41x | 1.18x | CN¥-57.37 Million |
| 2024 | 4.79% | 9.23% | 0.44x | 1.17x | CN¥-42.61 Million |
Industry Comparison
This section compares Beijing LabTech Instruments Co Ltd's net assets metrics with peer companies in the Scientific & Technical Instruments industry.
Industry Context
- Industry: Scientific & Technical Instruments
- Average net assets among peers: $865,454,265
- Average return on equity (ROE) among peers: 5.33%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Beijing LabTech Instruments Co Ltd (688056) | CN¥804.17 Million | 23.50% | 0.13x | $362.54 Million |
| Beijing BDStar Navigation Co Ltd (002151) | $688.09 Million | 6.00% | 0.34x | $3.25 Billion |
| Oriental Times Media Corp (002175) | $75.19 Million | 20.40% | 0.95x | $513.79 Million |
| Changchun UP Optotech Co Ltd (002338) | $840.05 Million | 5.20% | 0.18x | $2.14 Billion |
| Nanjing Sciyon Automation Group Co Ltd (002380) | $200.70 Million | 25.18% | 0.59x | $1.22 Billion |
| Beijing UniStrong Science & Technology Co Ltd (002383) | $285.64 Million | 28.39% | 0.38x | $1.01 Billion |
| Jiangsu Changfa Refrigeration Co Ltd (002413) | $351.64 Million | 18.36% | 1.54x | $2.54 Billion |
| Wuhan Guide Infrared Co Ltd (002414) | $4.35 Billion | 22.99% | 0.47x | $9.27 Billion |
| Shenzhen Jieshun Science and Technology Industry Co Ltd (002609) | $148.43 Million | 21.43% | 0.59x | $809.74 Million |
| Beijing SDL Technology Co Ltd (002658) | $1.07 Billion | 9.35% | 0.09x | $791.70 Million |
| Shenzhen Soling Industrial Co Ltd (002766) | $644.19 Million | -104.04% | 1.14x | $592.94 Million |
About Beijing LabTech Instruments Co Ltd
Beijing Labtech Instruments Co., Ltd. manufactures and supplies laboratorial products and solutions to laboratory industry worldwide. It offers water chillers, rotary evaporators, digestion blocks, vacuum pumps, and hot plates; AutoClean GPC cleanup, SepLine solid phase extraction, Sepath solid phase extraction, concentration systems, digestion systems, and evaporation systems; and analytical ins… Read more